Psoriasis and hypertension severity: Results from a case-control study

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Armstrong, April W ^a   Lin, Steven W ^a   Chambers, Cynthia J ^a   Sockolov, Mary E ^a   Chin, David L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PSORIASIS; RACE; SEX; DEMOGRAPHY; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 79953195488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018227     Document Type: Article

References (33)

1. Davidovici BB, Sattar N, Prinz JC, Puig L, Emery P, et al. (2010) Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130: 1785-1796.
2. Kaye JA, Li L, Jick SS, (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159: 895-902.
3. Qureshi AA, Choi HK, Setty AR, Curhan GC, (2009) Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 145: 379-382.
4. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, et al. (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55: 829-835.
5. Gisondi P, Girolomoni G, (2009) Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 35: 313-324.
6. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, et al. (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157: 68-73.
7. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, et al. (2007) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 56: 629-634.
8. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M, (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298: 321-328.
9. Huerta C, Rivero E, Rodriguez LA, (2007) Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143: 1559-1565.
10. McDonald CJ, Calabresi P, (1978) Psoriasis and occlusive vascular disease. Br J Dermatol 99: 469-475.
11. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, et al. (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156: 271-276.
12. Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD, (2008) Psoriasis and dyslipidaemia: a population-based study. Acta Derm Venereol 88: 561-565.
13. Shapiro Jea, (2006) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 56: 629-634.
14. Boehncke WH, Boehncke S, Schon MP, (2010) Managing comorbid disease in patients with psoriasis. BMJ 340: b5666.
15. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296: 1735-1741.
16. Mallbris L, Akre O, Granath F, Yin L, Lindelöf B, et al. (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19: 225-230.
17. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, et al. (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143: 1493-1499.
18. Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, et al. (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 217: 27-37.
19. Bettman S, (1926) Kapillarmikroskopische untersuchungen bei psoriasis. Dermat Wchnschr 83.
20. Braverman IM, (1972) Electron microscopic studies of the microcirculation in psoriasis. J Invest Dermatol 59: 91-98.
21. Kulka JP, (1964) Microcirculatory impairment as a factor in inflammatory tissue damage. Ann N Y Acad Sci 116: 1018-1044.
22. Lawler JC, Vineyard WR, (1960) The effect of treatment on the vascular component of the psoriatic lesion. Arch Dermatol 82: 190-193.
23. Cohen AD, Weitzman D, Dreiher J, (2010) Psoriasis and hypertension: a case-control study. Acta Derm Venereol 90: 23-26.
24. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, et al. (2009) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J.
25. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, et al. (2009) Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 145: 700-703.
26. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Date of Publication: 2004. Available: http://www.nhlbi.nih.gov/guidelines/hypertension/.
27. Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, et al. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356-362.
28. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, et al. (1999) Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104: 1693-1701.
29. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS, (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827.
30. Kim S, Iwao H, (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34.
31. Sowers JR, (2002) Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346: 1999-2001.
32. Bonifati C, Mussi A, Carducci M, D'auria L, Ameglio F, (1998) Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venereol 78: 22-26.
33. Altobelli E, Petrocelli R, Maccarone M, Altomare G, Argenziano G, et al. (2009) Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol 19: 252-256.